Evaluate

Evaluate combines pharma intelligence, machine-learning analytics, forecasting software, commercial datasets, and consulting. Its offerings support asset valuation, competitive monitoring, portfolio choices, licensing work, and market assessment.

Market and Competitive Intelligence

• Monitor competitors, pipelines, market events, regulatory milestones, news, and conference developments with visualizations, analyst commentary, and collaboration features.
• Answer bespoke market questions through continuous monitoring, deep dives, strategic workshops, and secondary market research.

Portfolio, Licensing, and Opportunity Decisions

• Assess acquisition and licensing targets through candidate generation, prioritization, partner identification, outreach support, asset valuation, and due diligence.
• Guide portfolio and product investment decisions with market sizing, commercial opportunity assessment, indication prioritization, forecasting, and portfolio strategy analysis.
• Answer asset, portfolio, and corporate strategy questions through more than 70 consultants, specializing in portfolio strategy, licensing and transaction advisory, and competitive intelligence.

Forecasting and Decision Analytics

• Forecast future revenue, units, patients, and patient flow using FC+ software modules for epidemiology, sales, oncology, and treatment trends.
• Evaluate asset commercial potential with machine-learning analysis of clinical-pipeline data, including predicted NPV, probability of technical and regulatory success, and peak-sales analytics.

Data, Population, and Trial Intelligence

• Analyze patient populations, segmentation, treatment use, and patient journeys to understand market opportunity, therapy use, and unmet need.
• Track clinical progress, trial designs and results, development pipelines, and clinical or regulatory events; deliver relevant data through Snowflake sharing, structured flat files, and selected APIs.

Best Fit

• Pharma and biotech teams evaluating assets, portfolios, licensing opportunities, product opportunities, competitors, and commercial forecasts.
• Commercial strategy, business development, portfolio, analytics, and consulting teams that need pharma intelligence, software, data delivery, or tailored analysis.